Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interventions
Magnitude Biosciences secures new investment to accelerate scaling of its specialist anti-ageing research services
Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevity, nutraceuticals and pharmaceutical industries, has closed a fourth round of investment to accelerate the scaling of its business.
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth
North East UK Biotech Magnitude Biosciences announces new CEO, Fozia Saleem, to accelerate the growth of the world leading C. elegans CRO.
Magnitude Biosciences Appoints New CEO Fozia Saleem to Drive Growth Read Post »
SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics
Biotech entrepreneur Ethan Perlstein works with Magnitude Biosciences to reveal a new target for ageing therapeutics.
SMER28 Extends Healthspan – Revealing a New Target for Ageing Therapeutics Read Post »
Ageing drug discovery biotech sees exciting early in vivo data for lead compound
Five Alarm Bio works with Magnitude Biosciences to develop therapeutics for age-related disease.
Ageing drug discovery biotech sees exciting early in vivo data for lead compound Read Post »
Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing
The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing researcher and entrepreneur David Weinkove, Associate Professor at the Department of Biosciences, Durham University and CEO of Magnitude Biosciences Ltd.
Fat Staining Assay Datasheet
Determine whether caloric restriction could be involved in your test compound’s mode of action.
Fat Staining Assay Datasheet Read Post »
Magnitude Biosciences, Perfectus Biomed Group and University of Kent Project Funded by National Biofilms Innovation Centre for Tackling and Exploiting Biofilms
The joint project for Magnitude Biosciences, Perfectus Biomed Group and the University of Kent aims to provide an assay to